Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Sodium butyrate | 156-54-7 | 99.8% | 500 MG
Supplier: Medchemexpress LLC HYB0350A500MG
Sodium Butyrate is an inhibitor of HDAC, exhibiting anti-tumor activity. It induces morphological changes, inhibits cell proliferation, and impairs cell viability in nasopharyngeal carcinoma (NPC) cells. It is for research use only.
- Inhibits HDAC activity.
- Possesses anti-tumor activity.
- Induces morphological changes and inhibits proliferation in NPC cells.
- Cytotoxic to NPC cells (5-8F and 6-10B cell lines).
- Promotes apoptosis in nasopharyngeal carcinoma cells.
- Reduces cell viability and key protein levels (p-mTOR, PCNA).
- Induces cell cycle arrest in the G0/G1 phase.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?